02-Jun-2021 | Facts and Factors
The Global ADME Toxicology Testing Market Is Powered By The Continuous Rise In Demand For Adme Toxicology Testing In Drug Research And Is Due To Technical Advancements In Toxicology Testing Which Are Driving ADME Toxicology Testing Growth Across The World.
In clinical trials on causes and systemic reactions like medicinal, chemical, and genetic reactions, ADME (absorption, distribution, metabolism, and excretion) toxicology testing is used to assess toxic reactions caused by molecules. This toxicology research techniques aid in the manufacture of successful drugs by limiting or preventing toxic reactions in the body. Toxicity thresholds are determined based on the outcomes of a series of experiments carried out in close to natural environments, which reflect almost real-time interactions between the agent and the host.
The demand for new medicines and biological products is increasing as disease incidence rises. This is one of the major reasons behind the use of ADME toxicology tests to avoid candidate drug failure in late-stage clinical trials. In addition, one of the major industry developments is the Food and Drug Administration's (FDA) launch of multiple guidance manuals that offer instruction on ADME properties when assessing the safety and effectiveness of a drug candidate. Apart from that, programme that calculates ADME automatically is gaining popularity as an alternative to traditional in vitro and in vivo studies. In addition, owing to the widespread outbreak of coronavirus disease (COVID-19) and the absence of an appropriate vaccine or cure, ADME toxicology research is being used to measure the effectiveness of existing medications as a potential treatment, which is boosting market development. The expansion of the ADME toxicology research industry has been aided by the COVID-19 pandemic. It's used to find potential COVID-19 drug candidates and to assess the cell model using ADME toxicology testing. As a result, demand for ADME toxicology research is projected to increase in 2020, boosting market share.
Detailed findings from the full report “ADME Toxicology Testing Market By Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Other Toxicities), By Method (Cellular Assay, Biochemical Assay, In-Silica, and Ex-Vivo), and By End-User (Cosmetics & Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026”. report at https://www.fnfresearch.com/adme-toxicology-testing-market.
In 2020, demand for the ADME toxicology testing market was regsitered at around USD 5.7 Billion, and current and expected developments by 2026 would reach an estimated USD 11.4 Billion. Companies and experts predict around 11.4% growth in the worldwide ADME toxicology testing market in terms of CAGR. The major factors for the global ADME toxicology testing industry are an increase in the number of drug advancements and an increase in demands from various pharmaceutical and biotechnology companies around the world as a result of lower costs associated with various studies during the drug development period. This demand will also be driven in the future by the use of in silico procedures that use PC-based research methods for faster results. Cell-based measures are now gaining a lot of traction around the world, and this demand will continue to grow in the future.
Major companies in the ADME toxicology testing market contain Promega Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Agilent Technologies, Accelrys, Inc., (Dassault Systemes BIOVIA), Catalent, Beckman Coulter, Inc., (Danaher), Covance, Inc. (LabCorp), Charles River Laboratories International, Inc., General Electric Company (Healthcare), Eurofins Scientific SE, Miltenyi Biotec, Life Technologies Corporation, Quintiles, among others.
The major drivers for the global ADME toxicology testing market are an increase in the number of drug developments, as well as increased demand from several biotechnology and pharmaceutical companies across the world. Because of reduced prices associated with multiple studies during the drug discovery period, faster time to market for new products, and a reduction in the number of drug fails that happened before, the number of drug failures has decreased. As a result, technical advances such as the use of in silico techniques, which use computer-based analytical methods for faster results, would fuel future demand. Modern cell-based assays are gaining widespread recognition and will continue to propel this demand in the future. To gain a larger share of the market, companies are now focusing on partnerships, developing new solutions, and improving their products. Growing interest among researchers in ADME toxicology testing due to technological advances. The number of clinical trials being conducted around the world is increasing due to rising healthcare expenditure. Health investment in the rest of the global economy is rising at a significant pace per year, according to the World Health Organization (WHO). Healthcare spending in low- and middle-income countries is increasing at a rate of about 6% per year, compared to 4% in developing countries. Governments around the world are providing an estimate of about 51% of a company's health budget. As a result of the growth in health-care costs, demand for ADME toxicology testing will rise over the projected period.
The ADME toxicology testing market is segmented as a technology, application, method, end-user, and region. By technology segment, the market is segmented into high throughput, OMICS technology, cell culture, and molecular imaging. By application segment, the market is segmented into renal toxicity, systemic toxicity, neurotoxicity, hepatotoxicity, and other toxicities. By method segment, the market is segmented into biochemical assay, cellular assay, ex-vivo, and in-silica. By end-user segment, the market is segmented into pharmaceutical industry, cosmetics & household products, food industry, animal industry, and others. Geographically, the global ADME toxicology testing market is divided into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.
In terms of geography, North America was the leading market share the global ADME toxicology testing market followed by Europe in 2019. North America is expected to dominate the growth of ADME toxicology testing due to the easy accessibility of diagnosis, and technical advances in the medical industry. The United States has the highest market share. In developed countries, the United States has a one-of-a-kind healthcare infrastructure. North America accounted leading market share of the market, with throughput/content filtering emerging as a significant contributor. This is due to continuous technical advances in the area, particularly in the United States. Drug research methods based on cell cultures have become increasingly common with businesses attempting to bring a new drug molecule to market. Due to expanded efforts for new medicinal molecules and the introduction of newer technology to raise the quality of medication being supplied, Asia Pacific is expected to rise at a substantial rate over the forecast years. China and Japan are important contributors to business expansion.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 5.4 Billion |
Projected Market Size in 2026 |
USD 11.4 Billion |
Growth Rate |
CAGR 11.4% |
Base Year |
2020 |
Forecast Years |
2021–2026 |
Key Market Players |
Thermo Fisher Scientific Inc., Promega Corporation, Beckman Coulter, Inc., (Danaher), Albany Molecular Research Inc., Eurofins Scientific SE, Life Technologies Corporation, Quintiles, Agilent Technologies, Accelrys, Inc., (Dassault Systemes BIOVIA), Catalent, Covance, Inc. (LabCorp), Charles River Laboratories International, Inc., General Electric Company (Healthcare), and Miltenyi Biotec among others.
|
Key Segment |
By Technology, By Application, By Method, End-User, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
By Technology
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
By Application
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Other Toxicities
By Method
- Cellular Assay
- Biochemical Assay
- In-Silica
- Ex-Vivo
By End-User
- Cosmetics & Household Products
- Pharmaceutical Industry
- Animal Industry
- Food Industry
- Others
Global ADME Toxicology Testing Market: Regional Segment Analysis
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- The Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle-East Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
